According to a recent Food and Drug Administration (FDA) press release, Watson Pharmaceuticals, Inc. has announced a voluntary recall of one lot of Propafenone HCL 225 mg tablets, an anti-arrhythmia drug. The tablets are being voluntarily recalled because some tablets may contain higher levels of the drug than is specified on the product labeling.
Although Watson Pharmaceuticals, Inc. is voluntarily recalling the product from general use, this action does not necessarily shield the company from liability should someone taking the anti-arrhythmia drug suffer serious harm from taking the incorrect dosage. The company is simply limiting the potential harm caused by the misdosage. The company’s self-interest in this case aligns with the interests of the general public, one of the intended benefits of a civil court system that allows pharmaceutical litigation to protect the interests of consumers.
If you have any questions regarding pharmaceutical liability lawsuits, or how liability and negligence encourages ethical behavior at the corporate level, please contact the Los Angeles liability attorneys at the Law Offices of Samer Habbas.
If you were hit by a car in Riverside, you need to act quickly to…
Legal Options and Wrongful Death Claims | Samer Habbas & Associates, PC On Friday morning,…
If you were injured in a truck accident in San Diego, you may be able…
Tour Bus Loaded With Passengers Involved in Major Collision With Commercial Truck Near The San Elijo…
If you were injured in a Los Angeles car accident, you may be wondering how…
Samer Habbas & Associates, PC Analyzes Legal Rights and Personal Injury Claims after Major Freeway…